We are live on ! Find out more
SCM

Silvant Capital Management Portfolio holdings

AUM $2.89B
1-Year Est. Return 34.45%
This Fund
S&P 500
This Quarter Est. Return
+1.23%
1 Year Est. Return
+34.45%
3 Year Est. Return
+148.47%
5 Year Est. Return
+205.7%
10 Year Est. Return
AUM
$560M
AUM Growth
-$74.7M
Cap. Flow
-$79.7M
Cap. Flow %
-14.23%
Top 10 Hldgs %
44.6%
Holding
340
New
9
Increased
8
Reduced
106
Closed
11

Top Buys

Rank Stock Value
1
DKNG icon
DraftKings
DKNG
+$1.29M
2
S icon
SentinelOne
S
+$1.15M
3
TSLA icon
Tesla
TSLA
+$1.08M
4
SPGI icon
S&P Global
SPGI
+$915K
5
UPS icon
United Parcel Service
UPS
+$856K

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$8.47M
2
AAPL icon
Apple
AAPL
+$8.37M
3
AMZN icon
Amazon
AMZN
+$5.31M
4
EQIX icon
Equinix
EQIX
+$3.27M
5
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$3.15M

Sector Composition

Rank Sector Weight
1 Technology 31.93%
2 Healthcare 14.26%
3 Consumer Discretionary 14.14%
4 Financials 13.68%
5 Communication Services 12.49%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MRO
326
DELISTED
Marathon Oil Corporation
MRO
$8K ﹤0.01%
616
STT icon
327
State Street
STT
$50.5B
$7K ﹤0.01%
83
APA icon
328
APA Corp
APA
$13B
$5K ﹤0.01%
228
AIV
329
Aimco
AIV
$387M
$3K ﹤0.01%
505
AMED
330
DELISTED
Amedisys
AMED
-866
Closed -$212K
BE icon
331
Bloom Energy
BE
$64.3B
-5,912
Closed -$159K
EHC icon
332
Encompass Health
EHC
$11.2B
-4,519
Closed -$282K
ESNT icon
333
Essent Group
ESNT
$6.15B
-5,699
Closed -$256K
KPTI icon
334
Karyopharm Therapeutics
KPTI
$44.6M
-759
Closed -$118K
OLLI icon
335
Ollie's Bargain Outlet
OLLI
$4.51B
-2,153
Closed -$181K
PRLB icon
336
Protolabs
PRLB
$1.92B
-2,883
Closed -$265K
SAM icon
337
Boston Beer
SAM
$1.94B
-309
Closed -$315K
TSEM icon
338
Tower Semiconductor
TSEM
$26.5B
-9,185
Closed -$270K
VRTX icon
339
Vertex Pharmaceuticals
VRTX
$119B
-10,731
Closed -$2.16M
CCMP
340
DELISTED
CMC Materials, Inc. Common Stock
CCMP
-3,536
Closed -$535K

Similar funds

Silvant Capital Management's Q3 2021 Portfolio in Review

As of Q3 2021, Silvant Capital Management held 340 positions worth $560M, down 12% from $635M the previous quarter. Its ten largest holdings account for 45% of the portfolio.

Silvant Capital Management withdrew a net $79.7M in Q3 2021, closing 11 positions and reducing 106 holdings. Its most notable exit was Vertex Pharmaceuticals, an estimated $2.16M position sold in full.

By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 32% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Silvant Capital Management opened a new position in SentinelOne worth $1.13M.

  • Silvant Capital Management's largest Q3 2021 buy was SentinelOne: 21,028 shares worth $1.13M.
  • Silvant Capital Management added most to DraftKings in Q3 2021, an estimated $1.29M increase.
  • Silvant Capital Management's biggest Q3 2021 reduction was Microsoft, cutting an estimated $8.47M.
  • Silvant Capital Management fully exited Vertex Pharmaceuticals in Q3 2021, selling an estimated $2.16M.
  • Silvant Capital Management's ten largest holdings make up 45% of its $560M portfolio in Q3 2021.
  • Silvant Capital Management opened 9 new positions and closed 11 in Q3 2021.
  • Silvant Capital Management's portfolio value fell 12% quarter-over-quarter to $560M.

Based on Silvant Capital Management's 13F filing for Q3 2021, filed 8 Nov 2021.